Benign prostatic hyperplasia: treatment in primary care.
Patel
Anand K
AK
Urology Research, J Floor, Royal Hallamshire Hospital, Sheffield S10 2JF.
Chapple
Christopher R
CR
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000368:Aged; D006801:Humans; D008297:Male; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000628:therapy*
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D010726:Phosphodiesterase Inhibitors